Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jul 16;26(1):392.
doi: 10.1186/s12882-025-04335-5.

Subtotal versus total parathyroidectomy: retrospective patient-centric outcomes in a chronic dialysis population

Affiliations
Observational Study

Subtotal versus total parathyroidectomy: retrospective patient-centric outcomes in a chronic dialysis population

Raymond Lin et al. BMC Nephrol. .

Abstract

Background: Hyperparathyroidism occurs commonly in the dialysis population, and surgical parathyroidectomy (PTx) is often required when medical therapy to suppress parathyroid hormone (PTH) fails. Surgical techniques include subtotal and total PTx, with or without auto-transplantation, with the choice of procedure generally determined by surgical preference rather than patient-related factors. The aim of this study was to compare outcomes of these surgical procedures, focusing on post-operative utilization of hospital resources, and biochemical and patient-level outcomes over the year following surgery.

Methods: This retrospective observational study included dialysis patients undergoing subtotal or total PTx (± auto-transplant) over 9-years at three tertiary-level hospitals in Sydney, Australia. Laboratory and patient-level-outcomes were compared immediately post-operatively and at one, three and 12-months.

Results: Of 64 dialysis patients undergoing PTx, 60.9% were male and the mean dialysis vintage was 5.9 (4.2) years. Total PTx was performed in 51, 46 with auto-transplantation, and subtotal PTx in 13. Patient characteristics were similar at baseline. Compared to subtotal PTx, total PTx resulted in lower post-operative calcium values (p = 0.01), higher intravenous calcium requirements (p = 0.03) and more frequent admission to intensive care (p = 0.03). After total PTx, the daily calcium and calcitriol pill burden at discharge was higher (median 25 (IQR 20-40) vs. 18 (IQR 6-26), p = 0.04) and at 3-months (p = 0.01), and 23.5% of patients were readmitted for calcium management (p = 0.05). At 12-months, more patients undergoing subtotal PTx had PTH values above guideline recommendations (42.9% vs. 9.3%, p = 0.02), pill burdens did not differ, and bone mineral density increased in both groups.

Conclusions: Total PTx requires greater post-operative resources but is associated with lower PTH values at 12-months, whereas subtotal PTx is associated with a lower pill burden but increased hyperparathyroidism recurrence. A tailored strategy is suggested, matching the surgical approach to patient needs.

Keywords: Auto-transplantation; Bone mineral density; Dialysis; Hyperparathyroidism; Subtotal parathyroidectomy; Total parathyroidectomy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All experimental protocols in the study were approved by the Nepean Blue Mountains Local Health District (NBMLHD) Low and Negligible Risk Subcommittee and ratified by the NBMLHD Human Research Ethics Committee (HREC 2025/ETH000321) in accordance with National Health and Medical Research Council’s “National Statement on Ethical Conduct in Human Research”. The ethical process is consistent with the Declaration of Helsinki. The study was reviewed as ‘Low or negligible risk’ and a waiver of usual requirement of consent for the use of re-identifiable information was granted. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Post-operative PTH, ALP and pill burden. (A) Parathyroid hormone levels (median) at baseline, 3-months and 12-months. (B) Alkaline phosphatase (median) at baseline, 1, 3 and 12-months. (C) Calcitriol dosage (mcg/day) (median) at discharge, 1-month, 3-months and 12-months. (D) Calcium carbonate dosage (mg/day) (median) at discharge, 1-month, 3-months and 12-month

Similar articles

References

    1. Drüeke TB. Hyperparathyroidism in Chronic Kidney Disease. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright © 2000-2024, MDText.com, Inc.; 2000
    1. Pimentel A, Ureña-Torres P, Bover J, Luis Fernandez-Martín J, Cohen-Solal M. Bone fragility fractures in CKD patients. Calcif Tissue Int. 2021;108(4):539–50. - PMC - PubMed
    1. KDIGO. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2011. 2017. (2017;7(1):1–59. - PMC - PubMed
    1. De Francisco ALM, Fresnedo GF, Rodrigo E, Piñera, Amado JA, Arias M. Parathyroidectomy in dialysis patients. Kidney Int. 2002;61:S161–6. - PubMed
    1. Iorga C, Iorga CR, Andreiana I, Bengulescu I, Constantin T, Strambu V. Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease. Front Endocrinol (Lausanne). 2023;14:1191914. - PMC - PubMed

LinkOut - more resources